Literature DB >> 9351728

Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.

M J Tanasijevic1, C P Cannon, D R Wybenga, G A Fischer, C Grudzien, C M Gibson, J W Winkelman, E M Antman, E Braunwald.   

Abstract

BACKGROUND: The availability of a reliable, noninvasive serum marker of reperfusion may permit early identification of patients with occlusion after thrombolysis who might benefit from further interventions.
METHODS: We measured myoglobin, creatine kinase MB (CK-MB), and cardiac troponin-I (cTnI) concentrations in sera obtained just before thrombolysis (T0) and 60 minutes later (T60) in 30 patients given TNK-tPA for acute myocardial infarction as part of the Thrombolysis in Myocardial Infarction (TIMI) 10A trial.
RESULTS: Angiography at T60 showed reperfusion (TIMI flow grade 2 to 3; n = 19) or occlusion (TIMI flow grade 0 to 1; n = 8). The median serum T60 concentration, the ratio of the T60 and T0 serum concentration, and the slope of increase over a 60-minute period for each serum marker were significantly higher in patients with patent arteries compared with patients with occluded arteries. The areas under the receiver operator characteristics curve for diagnosis of occlusion were 0.96, 0.91, and 0.87 for the T60 concentration of myoglobin, CK-MB and cTnI, respectively. Although the T60 levels of <469 ng/ml for myoglobin, <11.5 ng/ml for CK-MB, and < 1.1 ng/ml for cTnI identified all patients with occlusion, the specificity of myoglobin (94%) was higher than that of CK-MB (61%) and cTnI (67%). Similar results were obtained for the 60-minute ratios and 60-minute slopes for each marker, with indexes for myoglobin having the highest specificity.
CONCLUSIONS: In this pilot study, noninvasive diagnosis of occlusion 60 minutes after thrombolysis was achieved with a high degree of sensitivity and specificity with the myoglobin, CK-MB, and cTnI concentrations measured at that time point. These preliminary findings may permit a new strategy for assessment of the success of reperfusion, with triage to rescue angioplasty for patients in whom the 60-minute cardiac marker values or indexes are consistent with occlusion of the infarct-related artery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351728     DOI: 10.1016/s0002-8703(97)70044-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Evaluation of coronary artery patency using cardiac markers.

Authors:  Milenko J Tanasijevic
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

2.  Resolution of ST-segment elevation in acute myocardial infarction--early prognostic significance after thrombolytic therapy. Results from the COBALT trial.

Authors:  J Carlsson; U Kamp; D Härtel; J Brockmeier; R Meierhenrich; S Miketic; S Walter; F van de Werf; U Tebbe
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

3.  Typical rise and fall of troponin in (peri-procedural) myocardial infarction: A systematic review.

Authors:  Dianne van Beek; Bas van Zaane; Marjolein Looije; Linda Peelen; Wilton van Klei
Journal:  World J Cardiol       Date:  2016-03-26

4.  Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.

Authors:  M J de Groot; A M Muijtjens; M L Simoons; W T Hermens; J F Glatz
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

Review 5.  Cardiac Troponin Biosensor Designs: Current Developments and Remaining Challenges.

Authors:  Andreea Campu; Ilinca Muresan; Ana-Maria Craciun; Simona Cainap; Simion Astilean; Monica Focsan
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

6.  Atherosclerosis Risk Factors in Patients with Reactive Hypoglycemia.

Authors:  Małgorzata Landowska; Agata Żebrowska; Konrad Fajer; Patrycja Adamek; Aleksandra Kruk; Bernadetta Kałuża; Edward Franek
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-14       Impact factor: 3.249

7.  The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury.

Authors:  Fan Hu; Chi-Man Koon; Judy Yuet-Wa Chan; Kit-Man Lau; Kwok-Pui Fung
Journal:  BMC Complement Altern Med       Date:  2012-12-10       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.